Consensus
Conference on Patient Specific Therapy
November
2, 2003
Hyatt Regency
Bethesda, MD
Robert
K. Oldham, MD
Cancer Therapeutics, Thomasville, GA
Larry Kwak, MD, PhD
National Cancer Institute, Frederick, MD
Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute, Pittsburgh, PA
|
11:00am
|
Pick
Up Box Lunches
|
|
11:00-11:20am
|
Anti-Idiotypic
Antibodies - Kenneth A. Foon, MD
|
|
11:20-11:40am
|
Idiotype
Vaccines - Larry Kwak, MD, PhD
|
|
11:40am-12:00pm
|
T-cell
Therapy - Mark Dudley, PhD
|
|
12:00-12:20pm
|
Dendritic
Cell Therapy - Theresa Whiteside, PhD
|
|
12:20-12:40pm
|
Gene
Modified Tumor Vaccines - Kristen Hege, MD
|
|
12:40-1:00pm
|
Autologous
Tumor Vaccine Heat Shock Proteins - John Lewis, MD, PhD
|
|
1:00-1:20pm
|
Position
talk from NCI - Howard Streicher, MD
|
|
1:20-1:40pm
|
Position
talk from FDA - Raj Puri, MD, PhD
|
|
1:40-2:00pm
|
Position
talk from Industry - Robert Oldham, MD
|
|
2:00-2:30pm
|
Break
|
|
2:30-4:30pm
|
Panel
Discussion
|
Co-Chairs/Speakers:
Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Larry Kwak, MD, PhD
Nat'l Cancer Institute
Frederick, MD
Robert K. Oldham, MD
Univ. of Pittsburgh Cancer Institute
Thomasville, GA
Panelists:
Bob Bennett
CancerDrugsNow.Org
New York, NY
Michael Salgaller, PhD
Toucan Capital Corp.
Bethesda, MD
Speakers:
Mark Dudley, PhD
National Institutes of Health
Bethesda, MD
Kristen Hege, MD
Cell Genesys
South San Francisco, CA
Jonathan J. Lewis, MD, PhD
Antigenics, Inc.
New York, NY
Raj Puri, PhD
Food and Drug Administration
Bethesda, MD
Howard Streicher, MD
Cancer Therapy Evaluation Program
National Cancer Institute
Bethesda, MD
Theresa L. Whiteside, PhD
University of Pittsburgh Cancer Institute
Pittsburgh, PA
